Cannabinoid-based drugs as anti-inflammatory therapeutics

Toll-like receptor signalling

Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · see citing works

International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126 · see citing works

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · see citing works

International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works

Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide

Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142 · see citing works

The molecular logic of endocannabinoid signalling

Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957 · see citing works

Inflammation in Neurodegenerative Disease—A Double-Edged Sword

Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235 · see citing works

The endocannabinoid system and its therapeutic exploitation

Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · see citing works

Control of pain initiation by endogenous cannabinoids

Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,055 · see citing works

The Immunological Synapse

Bromley, S. K., Burack, R., Johnson, K. G., Somersalo, K., Sims, T. N., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.375 · Cited by 979 · see citing works

Chemokines: multiple levels of leukocyte migration control☆

Moser, B., Wolf, M., Walz, A., & Loetscher, P. (2004) · Trends in Immunology · doi:10.1016/j.it.2003.12.005 · Cited by 859 · see citing works

Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells

Weiner, H. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820117.x · Cited by 850 · see citing works

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827 · see citing works

2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB 1 receptor

Hanuš, L., Abu‐Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., Kustanovich, I. M., & Mechoulam, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061029898 · Cited by 761 · see citing works

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

Panikashvili, D., Simeonidou, C., Ben‐Shabat, S., Hanuš, L., Breuer, A., Mechoulam, R., & Shohami, E. (2001) · Nature · doi:10.1038/35097089 · Cited by 752 · see citing works

Cannabinoids: potential anticancer agents

Guzmán, M. (2003) · Nature Reviews. Cancer · doi:10.1038/nrc1188 · Cited by 740 · see citing works

The Role of Excitotoxicity in Neurodegenerative Disease

Doble, A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00042-4 · Cited by 723 · see citing works

Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation

Galve‐Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 684 · see citing works

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

Kingery, W. S. (1997) · Pain · doi:10.1016/s0304-3959(97)00049-3 · Cited by 678 · see citing works

Modulation of transmitter release via presynaptic cannabinoid receptors

Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671 · see citing works

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669 · see citing works

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A. A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 666 · see citing works

Cannabinoid physiology and pharmacology: 30 years of progress

Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608 · see citing works

Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients

Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589 · see citing works

Cannabinoids control spasticity and tremor in a multiple sclerosis model

Baker, D., Pryce, G., Croxford, J., Brown, P., Pertwee, R., Huffman, J. W., & Layward, L. (2000) · Nature · doi:10.1038/35003583 · Cited by 546 · see citing works

Evidence for a New G Protein-Coupled Cannabinoid Receptor in Mouse Brain

Breivogel, C. S., Griffin, G., Marzo, V. D., & Martin, B. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.155 · Cited by 537 · see citing works

The cannabinoid system and immune modulation

Klein, T., Newton, C. A., Larsen, K. A., Lu, L. D., Perkins, I., Nong, L., & Friedman, H. P. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0303101 · Cited by 524 · see citing works

A critical role for NF-κB in Gata3 expression and TH2 differentiation in allergic airway inflammation

Das, J., Chen, C.-H., Yang, L., Cohn, L., Ray, P., & Ray, A. (2001) · Nature Immunology · doi:10.1038/83158 · Cited by 518 · see citing works

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500 · see citing works

Activation of CB ₂ cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS

Ibrahim, M. M., Deng, H., Zvonok, A., Cockayne, D. A., Kwan, J., Mata, H. P., Vanderah, T. W., Lai, J., Porreca, F., Makriyannis, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834309100 · Cited by 491 · see citing works

The endogenous cannabinoid system protects against colonic inflammation

Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G., Sibaev, A., Storr, M., & Lutz, B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19465 · Cited by 461 · see citing works

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation

PETROCELLIS, L. D., Melck, D. J., Palmisano, A., Bisogno, T., Laezza, C., Bifulco, M., & Marzo, V. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8375 · Cited by 412 · see citing works

Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotension

Varga, K., Wagner, J. A., Bridgen, D. T., & Kunos, G. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.11.1035 · Cited by 410 · see citing works

The endogenous cannabinoid system protects against colonic inflammation

Massa, F., Marsicano, G., Hermann, H., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419465 · Cited by 387 · see citing works

Endocannabinoids control spasticity in a multiple sclerosis model

Baker, D., Pryce, G., Croxford, J. L., Brown, P., Pertwee, R. G., Makriyannis, A., Khanolkar, A. D., Layward, L., Fezza, F., Bisogno, T., et al. (2000) · The FASEB Journal · doi:10.1096/fj.00-0399fje · Cited by 378 · see citing works

Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance

Sugiura, T., Kobayashi, Y., Oka, S., & Waku, K. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0356 · Cited by 346 · see citing works

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

Carlisle, S. J., Marciano‐Cabral, F., Staab, A., LUDWICK, C., & Cabral, G. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00147-3 · Cited by 344 · see citing works

The therapeutic potential of cannabis

Baker, D., Pryce, G., Giovannoni, G., & Thompson, A. J. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00381-8 · Cited by 344 · see citing works

Cannabinoids inhibit neurodegeneration in models of multiple sclerosis

Pryce, G., Ahmed, Z., Hankey, D. J. R., Jackson, S. J., Croxford, J. L., Pocock, J. M., Ledent, C. A., Petzold, A., Thompson, A. J., Giovannoni, G., et al. (2003) · Brain · doi:10.1093/brain/awg224 · Cited by 342 · see citing works

Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant

Shohami, E., Gallily, R., Mechoulam, R., Bass, R., & Ben‐Hur, T. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00181-6 · Cited by 337 · see citing works

Therapeutic Action of Cannabinoids in a Murine Model of Multiple Sclerosis

Arévalo‐Martín, Á., Vela, J. M., Molina‐Holgado, E., Borrell, J. I., & Guaza, C. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02511.2003 · Cited by 314 · see citing works

Biosynthesis and inactivation of the endocannabinoid 2‐arachidonoylglycerol in circulating and tumoral macrophages

Marzo, V. D., Bisogno, T., PETROCELLIS, L. D., Melck, D. J., Orlando, P., Wagner, J. A., & Kunos, G. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00631.x · Cited by 296 · see citing works

Cannabinoid receptors and the regulation of immune response

Berdyshev, E. V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00195-x · Cited by 280 · see citing works

Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide

Facchinetti, F., Giudice, E. D., Furegato, S., Passarotto, M., & Leon, A. (2002) · Glia · doi:10.1002/glia.10177 · Cited by 275 · see citing works

Cannabinoid CB1‐receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation

Izzo, A. A., Fezza, F., Capasso, R., Bisogno, T., Pinto, L., Iuvone, T., Esposito, G., Mascolo, N., Marzo, V. D., & Capasso, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704293 · Cited by 255 · see citing works

Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain

Szabó, I., Chen, X.-H., Li, X., Adler, M. W., Howard, O. M. Z., Oppenheim, J. J., & Rogers, T. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102327699 · Cited by 255 · see citing works

Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway

Zhu, L. X., Sharma, S. P., Stolina, M., Gardner, B. K., Roth, M. D., Tashkin, D. P., & Dubinett, S. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.373 · Cited by 250 · see citing works

Production of Eicosanoids and Other Oxylipins by Pathogenic Eukaryotic Microbes

Noverr, M. C., Erb‐Downward, J. R., & Huffnagle, G. B. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.3.517-533.2003 · Cited by 241 · see citing works

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled, crossover study

Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms1048oa · Cited by 239 · see citing works

Cannabinoid receptors and immunity

Klein, T., Newton, C. A., & Friedman, H. P. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01300-0 · Cited by 235 · see citing works

Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells

Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., & Roth, M. D. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00370-3 · Cited by 234 · see citing works

Marijuana and Cocaine Impair Alveolar Macrophage Function and Cytokine Production

Baldwin, G. C., Tashkin, D. P., Buckley, D. M., PARK, A. N., Dubinett, S. M., & Roth, M. D. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.5.9704146 · Cited by 230 · see citing works

Cannabinoids and brain injury: therapeutic implications

Mechoulam, R. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02276-1 · Cited by 229 · see citing works

Effects of cannabinoids on LPS‐stimulated inflammatory mediator release from macrophages: Involvement of eicosanoids

Chang, Y., Lee, S. T., & Lin, W. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1103 · Cited by 219 · see citing works

The Cannabinoid System and Cytokine Network

Klein, T., Lane, B., Newton, C. A., & Friedman, H. P. (2000) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22501.x · Cited by 216 · see citing works

Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis

Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90075-1 · Cited by 200 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17652 · Cited by 195 · see citing works

Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells

Marzo, V. D., PETROCELLIS, L. D., Sepe, N., & BUONO, A. (1996) · Biochemical Journal · doi:10.1042/bj3160977 · Cited by 195 · see citing works

Endogenous Interleukin-1 Receptor Antagonist Mediates Anti-Inflammatory and Neuroprotective Actions of Cannabinoids in Neurons and Glia

Molina‐Holgado, F., Pinteaux, E., Moore, J. D., Molina‐Holgado, E., Guaza, C., Gibson, R. M., & Rothwell, N. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-16-06470.2003 · Cited by 192 · see citing works

Cannabinol Derivatives: Binding to Cannabinoid Receptors and Inhibition of Adenylylcyclase

Rhee, M. H., Vogel, Z., Barg, J., Bayewitch, M. L., Levy, R., Hanuš, L., Breuer, A., & Mechoulam, R. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm970126f · Cited by 192 · see citing works

Endocannabinoids as physiological regulators of colonic propulsion in mice

Pinto, L., Izzo, A. A., Mascolo, N., Capasso, F., Cascio, M. G., Bisogno, T., Marzo, V. D., Hospodar–Scott, K., & Brown, D. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34242 · Cited by 180 · see citing works

Presence and regulation of the endocannabinoid system in human dendritic cells

Matias, I., Pochard, P., Orlando, P., Salzet, M., Pestel, J., & Marzo, V. D. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03078.x · Cited by 178 · see citing works

Neuroprotection by the Endogenous Cannabinoid Anandamide and Arvanil againstIn VivoExcitotoxicity in the Rat: Role of Vanilloid Receptors and Lipoxygenases

Veldhuis, W. B., van der Stelt, M., Wadman, M. W., van Zadelhoff, G., Maccarrone, M., Fezza, F., Veldink, G. A., Vliegenthart, J. F. G., Bär, P. R., Nicolay, K., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04127.2003 · Cited by 175 · see citing works

Cannabinoids and glaucoma

Tomida, I. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.032250 · Cited by 172 · see citing works

Effects of Cannabinoid Receptor Agonist and Antagonist Ligands on Production of Inflammatory Cytokines and Anti-Inflammatory Interleukin-10 in Endotoxemic Mice

Smith, S. R., Terminelli, C., & Denhardt, G. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39213-4 · Cited by 170 · see citing works

Cornerstone of peripheral tolerance: naturally occurring CD4+CD25+ regulatory T cells

Piccirillo, C. A., & Thornton, A. M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.04.009 · Cited by 167 · see citing works

Lipopolysaccharide Downregulates Fatty Acid Amide Hydrolase Expression and Increases Anandamide Levels in Human Peripheral Lymphocytes

Maccarrone, M., PETROCELLIS, L. D., Bari, M., Fezza, F., Salvati, S., Marzo, V. D., & Finazzi‐Agrò, A. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2500 · Cited by 162 · see citing works

Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial*

Knoller, N., Levi, L., Shoshan, I., Reichenthal, E., Razon, N., Rappaport, Z. H., & Biegon, A. R. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00009 · Cited by 161 · see citing works

Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R(+)WIN55,212

Croxford, J. L., & Miller, S. D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317652 · Cited by 160 · see citing works

Δ9-Tetrahydrocannabinol Treatment Suppresses Immunity and Early IFN-γ, IL-12, and IL-12 Receptor β2 Responses to Legionella pneumophila Infection

Klein, T., Newton, C. A., Nakachi, N., & Friedman, H. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6461 · Cited by 159 · see citing works

CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids

McAllister, S. D., & Glass, M. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0344 · Cited by 158 · see citing works

A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., & Marzo, V. D. (2004) · The FASEB Journal · doi:10.1096/fj.04-1754fje · Cited by 152 · see citing works

Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease

Cabral, G. A., & Pettit, D. A. D. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00227-0 · Cited by 151 · see citing works

Effects of cannabinoid receptor‐2 activation on accelerated gastrointestinal transit in lipopolysaccharide‐treated rats

Mathison, R., Ho, W., Pittman, Q. J., Davison, J. S., & Sharkey, K. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705889 · Cited by 141 · see citing works

Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection

Newton, C., Klein, T., & Friedman, H. P. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.4015-4020.1994 · Cited by 140 · see citing works

A novel synthetic, nonpsychoactive cannabinoid acid (HU‐320) with antiinflammatory properties in murine collagen‐induced arthritis

Sumariwalla, P. F., Gallily, R., Tchilibon, S., Fride, E., Mechoulam, R., & Feldmann, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20050 · Cited by 134 · see citing works

Clustering of MHC–peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains

Vogt, A. B., Spindeldreher, S., & Kropshofer, H. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.18912.x · Cited by 131 · see citing works

Simultaneous Measurement of Anandamide and 2-Arachidonoylglycerol by Polymyxin B-Selective Adsorption and Subsequent High-Performance Liquid Chromatography Analysis: Increase in Endogenous Cannabinoids in the Sera of Patients with Endotoxic Shock

Wang, Y., Liu, Y., Ito, Y., Hashiguchi, T., Kitajima, I., Yamakuchi, M., Shimizu, H., Matsuo, S., Imaizumi, H., & Maruyama, I. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5015 · Cited by 129 · see citing works

Activation and Binding of Peroxisome Proliferator-Activated Receptor γ by Synthetic Cannabinoid Ajulemic Acid

Liu, J., Li, H., Burstein, S. H., Zurier, R. B., & Chen, J. D. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.983 · Cited by 129 · see citing works

Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN

Filippo, C. D., Rossi, F., Rossi, S., & D’Amico, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0703303 · Cited by 128 · see citing works

Suppression of experimetal autoimmune encephalomyelitis by cannabinoids

Wirguin, I., Mechoulam, R., Breuer, A., Schezen, E., Weidenfeld, J., & Brenner, T. (1994) · Immunopharmacology · doi:10.1016/0162-3109(94)90056-6 · Cited by 117 · see citing works

Selective Diapedesis of Th1 Cells Induced by Endothelial Cell RANTES

Kawai, T., Seki, M., Hiromatsu, K., Eastcott, J. W., Watts, G. F. M., Sugai, M., Smith, D. J., Porcelli, S. A., & Taubman, M. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3269 · Cited by 114 · see citing works

Win 55212-2, a cannabinoid receptor agonist, attenuates leukocyte/endothelial interactions in an experimental autoimmune encephalomyelitis model

Ni, X., Geller, E. B., Eppihimer, M. J., Eisenstein, T. K., Adler, M. W., & Tuma, R. F. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1009oa · Cited by 114 · see citing works

2-Arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces the migration of EoL-1 human eosinophilic leukemia cells and human peripheral blood eosinophils

Oka, S., Ikeda, S., Kishimoto, S., Gokoh, M., Shin, Y., Waku, K., & Sugiura, T. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404252 · Cited by 108 · see citing works

The Cannabinoid Acids

BURSTEIN, S. H. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00069-2 · Cited by 107 · see citing works

Advances in pharmacotherapy for tobacco dependence

Foulds, J., Burke, M. V., Steinberg, M. B., Williams, J. M., & Ziedonis, D. M. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/eoed.9.1.39.32951 · Cited by 107 · see citing works

Differential expression of cannabinoid CB2 receptor mRNA in mouse immune cell subpopulations and following B cell stimulation

Lee, S. F., Newton, C. A., Widen, R. E., Friedman, H. P., & Klein, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01122-0 · Cited by 98 · see citing works

Genomic and Functional Changes Induced by the Activation of the Peripheral Cannabinoid Receptor CB2 in the Promyelocytic Cells HL-60

Derocq, J., Jbilo, O., Bouaboula, M., Ségui, M., Clère, C., & Casellas, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15621 · Cited by 98 · see citing works

Dimethylheptyl-THC-11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure

Zurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199801)41:1 · Cited by 96 · see citing works

IFN-γ Affects Homing of Diabetogenic T Cells

Savinov, A. Y., Wong, F. S., & Chervonsky, A. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6637 · Cited by 95 · see citing works

Membrane Cholesterol But Not Putative Receptors Mediates Anandamide–Induced Hepatocyte Apoptosis

Biswas, K. K., Sarker, K. P., Abeyama, K., Kawahara, K.-I., Iino, S., Otsubo, Y., Saigo, K., Izumi, H., Hashiguchi, T., Yamakuchi, M., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50459 · Cited by 90 · see citing works

2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, Induces Accelerated Production of Chemokines in HL-60 Cells

Kishimoto, S. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh063 · Cited by 88 · see citing works

Cannabinoid receptors and T helper cells

Klein, T., Newton, C. A., Larsen, K. A., Chou, J., Perkins, I., Lu, L. D., Nong, L., & Friedman, H. P. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.019 · Cited by 87 · see citing works

Cannabinoid receptor antagonists and obesity.

Black, S. C. (2004) · PubMed · Cited by 84 · see citing works

Delta 9-tetrahydrocannabinol inhibition of tumor necrosis factor-alpha: suppression of post-translational events.

Fischer‐Stenger, K., Pettit, D. A. D., & Cabral, G. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39607-2 · Cited by 82 · see citing works

The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner

Alberich-Jordà, M., Rayman, N., Tas, M., Verbakel, S. E., Battista, N., van Lom, K., Löwenberg, B., Maccarrone, M., & Delwel, R. (2004) · Blood · doi:10.1182/blood-2003-12-4357 · Cited by 79 · see citing works

Regulation of interleukin-12 production byG-protein-coupled receptors

Braun, M., & Kelsall, B. L. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01357-5 · Cited by 77 · see citing works

Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila.

Klein, T., Newton, C., Widen, R. H., & Friedman, H. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39360-2 · Cited by 76 · see citing works

The endogenous cannabinoid 2‐arachidonoyl glycerol as in vivo chemoattractant for dendritic cells and adjuvant for Th1 response to a soluble protein

Maestroni, G. J. M. (2004) · The FASEB Journal · doi:10.1096/fj.04-2190fje · Cited by 72 · see citing works

Modulation of the Immune System in Cannabis Users

Pacifici, R. (2003) · JAMA · doi:10.1001/jama.289.15.1929-b · Cited by 71 · see citing works

Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation.

Daaka, Y., Friedman, H. P., & Klein, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12361-6 · Cited by 70 · see citing works

In vitro and in vivo suppressive effects of delta-9-tetrahydrocannabinol on interferon production by murine spleen cells

Blanchard, D. K., Newton, C. A., Klein, T., Stewart, W. E., & Friedman, H. P. (1986) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(86)90020-2 · Cited by 69 · see citing works

Protection Against Septic Shock and Suppression of Tumor Necrosis Factor α and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid

Gallily, R., Yamin, A., Waksmann, Y., Ovadia, H., Weidenfeld, J., Bar-Joseph, A., Biegon, A. R., Mechoulam, R., & Shohami, E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37086-7 · Cited by 69 · see citing works

Modulation of the Immune System in Cannabis Users

Pacifici, R., Zuccaro, P., Pichini, S., et al. (2003) · JAMA · doi:10.1001/jama.289.15.1929-a · Cited by 68 · see citing works

Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid.

Gallily, R., Yamin, A., Waksmann, Y., Ovadia, H., Weidenfeld, J., Bar-Joseph, A., Biegon, A. R., Mechoulam, R., & Shohami, E. (1997) · PubMed · Cited by 67 · see citing works

Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid

Zurier, R. B., Rossetti, R. G., BURSTEIN, S. H., & Bidinger, B. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01604-0 · Cited by 62 · see citing works

γ-Irradiation Enhances Apoptosis Induced by Cannabidiol, a Non-psychotropic Cannabinoid, in Cultured HL-60 Myeloblastic Leukemia Cells

Gallily, R., Even-Chen, T., Katzavian, G., Lehmann, D., Dagan, A., & Mechoulam, R. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819031000103917 · Cited by 62 · see citing works

Functional assessment of neuronal cannabinoid receptors in the muscular layers of human ileum and colon

Manara, L., Croci, T., Guagnini, F., Rinaldi, M. L., Maffrand, J., Fur, G. L., Mukenge, S., & Ferla, G. (2002) · Digestive and Liver Disease · doi:10.1016/s1590-8658(02)80146-3 · Cited by 59 · see citing works

9-Tetrahydrocannabinol Decreases Alpha/Beta Interferon Response to Herpes Simplex Virus Type 2 in the B6C3F1 Mouse

Cabral, G. A., Lockmuller, J. C., & Mishkin, E. M. (1986) · Experimental Biology and Medicine · doi:10.3181/00379727-181-42258 · Cited by 59 · see citing works

1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.

Dajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M., Dayton, M. T., & Mir, G. (1999) · PubMed · Cited by 57 · see citing works

9-Tetrahydrocannabinol, Cytokines, and Immunity to Legionella pneumophila

Klein, T., Newton, C., Zhu, W., Daaka, Y., & Friedman, H. P. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-209-43897b · Cited by 56 · see citing works

Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β

Gardner, B. K., Zu, L. X., Sharma, S. P., Liu, Q., Makriyannis, A., Tashkin, D. P., & Dubinett, S. M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6179 · Cited by 55 · see citing works

Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.

Herring, A. C., & Kaminski, N. E. (1999) · PubMed · Cited by 53 · see citing works

Distinct Expression Profiles of the Peripheral Cannabinoid Receptor in Lymphoid Tissues Depending on Receptor Activation Status

Rayman, N., Lam, K. H., Laman, J. D., Simons, P. J., Löwenberg, B., Sonneveld, P., & Delwel, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2111 · Cited by 49 · see citing works

Cannabinoids act backwards

Christie, M. J., & Vaughan, C. W. (2001) · Nature · doi:10.1038/35069167 · Cited by 48 · see citing works

Endocannabinoid Degradation, Endotoxic Shock and Inflammation

Maccarrone, M., Bari, M., Battista, N., & Finazzi‐Agrò, A. (2002) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010023344878 · Cited by 48 · see citing works

delta 9-Tetrahydrocannabinol enhances the secretion of interleukin 1 from endotoxin-stimulated macrophages.

Zhu, W., Newton, C. A., Daaka, Y., Friedman, H., & Klein, T. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22543-5 · Cited by 47 · see citing works

The therapeutic potential of cannabis in multiple sclerosis

Baker, D., & Pryce, G. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.4.561 · Cited by 39 · see citing works

Anti-CD40, anti-CD3, and IL-2 stimulation induce contrasting changes in CB1 mRNA expression in mouse splenocytes

Noe, S. N., Newton, C. A., Widen, R. E., Friedman, H., & Klein, T. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00349-0 · Cited by 38 · see citing works

Cannabinoids cool the intestine

Kunos, G., & Pacher, P. (2004) · Nature Medicine · doi:10.1038/nm0704-678 · Cited by 37 · see citing works

Modulation of cytokine responses in Corynebacterium parvum-primed endotoxemic mice by centrally administered cannabinoid ligands

Smith, S. R., Terminelli, C., & Denhardt, G. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01142-6 · Cited by 32 · see citing works

1′,1′-Dimethylheptyl-Δ-8-tetrahydrocannabinol-11-oic Acid: A Novel, Orally Effective Cannabinoid with Analgesic and Anti-inflammatory Properties

Dajani, E. Z., Larsen, K. R., Taylor, J., Dajani, N. E., Shahwan, T. G., Neeleman, S. D., Taylor, M. S., Dayton, M. T., & Mir, G. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35067-0 · Cited by 25 · see citing works

The THC-induced suppression of Th1 polarization in response toLegionella pneumophilainfection is not mediated by increases in corticosterone and PGE2

Newton, C. A., Lu, T., Nazian, S. J., Perkins, I., Friedman, H. P., & Klein, T. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304184 · Cited by 21 · see citing works

Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease

Mendizábal, V. E., & Adler‐Graschinsky, E. (2003) · Current Vascular Pharmacology · doi:10.2174/1570161033476583 · Cited by 21 · see citing works

Pain reduction and lack of psychotropic effects with ajulemic acid: Comment on the article by Sumariwalla et al

BURSTEIN, S. H., & Zurier, R. B. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20805 · Cited by 11 · see citing works

Dimethylheptyl-THC-11-oic Acid

Zurier, R. B., Rossetti, R. G., Lane, J. H., Goldberg, J. M., Hunter, S. A., & BURSTEIN, S. H. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_49 · Cited by 8 · see citing works

Newton, C. A. et al. The THC-induced suppression of TH1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J. Leukoc. Biol. 76, 854-861

Perkins, I., Lu, T., Nazian, S. J., Newton, C. A., Friedman, H. P., & Klein, T. (2004) · Cited by 3 · see citing works

The Endocannabinoid System as an Emerging Target of Pharmacotherapy

Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works

Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers

Gillison, M. L., DʼSouza, G., Westra, W. H., Sugar, E. A., Xiao, W., Begum, S., & Viscidi, R. P. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn025 · Cited by 1,548 · see citing works

Beta-caryophyllene is a dietary cannabinoid.

Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906 · see citing works

Targeting the endocannabinoid system: to enhance or reduce?

Marzo, V. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798 · see citing works

Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ

Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. S. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 667 · see citing works

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology

Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 484 · see citing works

The Endocannabinoid Anandamide Protects Neurons during CNS Inflammation by Induction of MKP-1 in Microglial Cells

Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445 · see citing works

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 420 · see citing works

Novel cannabinoid receptors

Brown, A. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707481 · Cited by 410 · see citing works

Emerging role of the cannabinoid receptor CB ₂ in immune regulation: therapeutic prospects for neuroinflammation

Cabral, G. A., & Griffin-Thomas, L. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399409000957 · Cited by 408 · see citing works

Modulating the endocannabinoid system in human health and disease – successes and failures

Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 406 · see citing works

Steroid hormone receptor expression and function in microglia

Sierra, A., Gottfried‐Blackmore, A., Milner, T. A., McEwen, B. S., & Bulloch, K. (2008) · Glia · doi:10.1002/glia.20644 · Cited by 405 · see citing works

CB 1 and CB 2 Receptor Pharmacology

Howlett, A. C., & Abood, M. E. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.007 · Cited by 385 · see citing works

Cannabinoids and Pain: New Insights From Old Molecules

Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01259 · Cited by 417 · see citing works

Frontiers in pruritus research: scratching the brain for more effective itch therapy

Paus, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28553 · Cited by 368 · see citing works

Endocannabinoids and the control of energy balance

Matias, I., & Marzo, V. D. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.11.006 · Cited by 367 · see citing works

Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease

Kendall, D. A., & Yudowski, G. A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00294 · Cited by 363 · see citing works

Bioactive lipids, inflammation and chronic diseases

Leuti, A., Fazio, D., Fava, M., Piccoli, A., Oddi, S., & Maccarrone, M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.028 · Cited by 368 · see citing works

Cannabis and adolescent brain development.

Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360 · see citing works

Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System

Karsak, M., Gaffal, E., Date, R., Wang‐Eckhardt, L., Rehnelt, J., Petrosino, S., Starowicz, K., Steuder, R., Schlicker, E., Cravatt, B. F., et al. (2007) · Science · doi:10.1126/science.1142265 · Cited by 338 · see citing works

The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases

Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303 · see citing works

The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain

Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301 · see citing works

Cannabinoid receptors as novel targets for the treatment of melanoma

Blázquez, C., Carracedo, A., Barrado, L., Real, P. J., Fernández-Luna, J. L., Velasco, G., Malumbres, M., & Guzmán, M. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 293 · see citing works

Cannabinoid CB 2 receptors in human brain inflammation

Benito, C., Tolón, R. M., Pazos, M. R., Núñez, E., Castillo, A. I., & Romero, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707505 · Cited by 293 · see citing works

Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation

Galve‐Roperh, I., Chiurchiù, V., Díaz-Alonso, J., Bari, M., Guzmán, M., & Maccarrone, M. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.05.004 · Cited by 280 · see citing works

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

Bı́ró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.004 · Cited by 277 · see citing works

Cannabinoid CB 2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation

Wright, K. L., Duncan, M., & Sharkey, K. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 269 · see citing works

CB2-receptor stimulation attenuates TNF-α-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion

Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Huffman, J. W., Csiszár, A., Ungvari, Z. I., Mackie, K., Chatterjee, S. B., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00688.2007 · Cited by 262 · see citing works

Alkylamides from Echinacea Are a New Class of Cannabinomimetics

Raduner, S., Majewska, A., Chen, J., Xie, X., Hamon, J., Faller, B., Altmann, K., & Gertsch, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601074200 · Cited by 258 · see citing works

Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

Bátkai, S., Osei‐Hyiaman, D., Pan, H., El-Assal, O. N., Rajesh, M., Mukhopadhyay, P., Hong, F., Harvey-White, J. D., Jafri, A., Haskó, G., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7451com · Cited by 246 · see citing works

Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

Martín-Moreno, A. M., Brera, B., Spuch, C., Carro, E., García‐García, L., Delgado, M., Pozo, M. A., Innamorato, N. G., Cuadrado, A., & CEBALLOS, M. L. D. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-8 · Cited by 246 · see citing works

β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway

Bento, A. F., Marcon, R., Dutra, R. C., Claudino, R. F., Cola, M., Leite, D. F. P., & Calixto, J. Β. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.052 · Cited by 237 · see citing works

Endocannabinoids and immune regulation☆

Pandey, R., Mousawy, K. M., Nagarkatti, M., & Nagarkatti, P. S. (2009) · Pharmacological Research · doi:10.1016/j.phrs.2009.03.019 · Cited by 232 · see citing works

Cannabinoid CB2 Receptor Potentiates Obesity-Associated Inflammation, Insulin Resistance and Hepatic Steatosis

Deveaux, V., Cadoudal, T., Ichigotani, Y., Teixeira-Clerc, F., Louvet, A., Manin, S., Nhieu, J. T. V., Belot, M., Zimmer, A., Even, P. C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005844 · Cited by 228 · see citing works

Cannabinoids in health and disease

Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 227 · see citing works

Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.

Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217 · see citing works

Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis

Wilkinson, J. D., & Williamson, E. M. (2006) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.10.009 · Cited by 213 · see citing works

Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption

Rajesh, M., Mukhopadhyay, P., Bátkai, S., Haskó, G., Liaudet, L., Drel, V. R., Obrosova, I. G., & Pacher, P. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00236.2007 · Cited by 211 · see citing works

Cannabinoid receptor 2 mediates the retention of immature B cells in bone marrow sinusoids

Pereira, J. P., An, J., Xu, Y., Huang, Y., & Cyster, J. G. (2009) · Nature Immunology · doi:10.1038/ni.1710 · Cited by 210 · see citing works

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Shoemaker, J. L., Seely, K. A., Reed, R. L., Crow, J. P., & Prather, P. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04346.x · Cited by 208 · see citing works

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

Centonze, D., Bari, M., Rossi, S., Prosperetti, C., Furlan, R., Fezza, F., De Chiara, V., Battistini, L., Bernardi, G., Bernardini, S., et al. (2007) · Brain · doi:10.1093/brain/awm160 · Cited by 207 · see citing works

New horizons for newborn brain protection: enhancing endogenous neuroprotection

Hassell, K. J., Ezzati, M., Alconada, D. A., Hausenloy, D. J., & Robertson, N. J. (2015) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2014-306284 · Cited by 200 · see citing works

Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease

Javed, H., Azimullah, S., Haque, M. E., & Ojha, S. K. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00321 · Cited by 199 · see citing works

CB2 cannabinoid receptor agonists attenuate TNF‐α‐induced human vascular smooth muscle cell proliferation and migration

Rajesh, M., Mukhopadhyay, P., Haskó, G., Huffman, J. W., Mackie, K., & Pacher, P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707569 · Cited by 198 · see citing works

Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages

Sugamura, K., Sugiyama, S., Nozaki, T., Matsuzawa, Y., Izumiya, Y., Miyata, K., Nakayama, M., Kaikita, K., Obata, T., Takeya, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.811992 · Cited by 196 · see citing works

GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils

Balenga, N. A. B., Aflaki, E., Kargl, J., Platzer, W., Schröder, R. J., Blättermann, S., Kostenis, E., Brown, A. J., Heinemann, Á., & Waldhoer, M. (2011) · Cell Research · doi:10.1038/cr.2011.60 · Cited by 194 · see citing works

Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease

Basu, S., & Dittel, B. N. (2011) · Immunologic Research · doi:10.1007/s12026-011-8210-5 · Cited by 191 · see citing works

Cannabinoid Receptor Agonist-induced Apoptosis of Human Prostate Cancer Cells LNCaP Proceeds through Sustained Activation of ERK1/2 Leading to G1 Cell Cycle Arrest

Sarfaraz, S., Afaq, F., Adhami, V. M., Malik, A., & Mukhtar, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603495200 · Cited by 188 · see citing works

Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

Deng, H., & Li, W. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.006 · Cited by 182 · see citing works

The endocannabinoid system in targeting inflammatory neurodegenerative diseases

Centonze, D., Finazzi‐Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 180 · see citing works

The endocannabinoid system as a target for the treatment of neurodegenerative disease

Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 181 · see citing works

Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation

Zhang, Y.-Q., Catts, V. S., Sheedy, D. L., McCrossin, T., Kril, J. J., & Weickert, C. S. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.238 · Cited by 176 · see citing works

Endotoxic fever: New concepts of its regulation suggest new approaches to its management

Blatteis, C. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.013 · Cited by 172 · see citing works

Cannabinoid-Induced Immune Suppression and Modulation of Antigen-Presenting Cells

Klein, T. W., & Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-005-9007-x · Cited by 172 · see citing works

Plant, Synthetic, and Endogenous Cannabinoids in Medicine

Marzo, V. D., & PETROCELLIS, L. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.57.011205.135648 · Cited by 170 · see citing works

Intracellular trafficking of anandamide: new concepts for signaling

Maccarrone, M., Dainese, E., & Oddi, S. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.05.008 · Cited by 169 · see citing works

The CB2 Cannabinoid Receptor Controls Myeloid Progenitor Trafficking

Palazuelos, J., Davoust, N., Julien, B., Hatterer, E., Aguado, T., Mechoulam, R., Benito, C., Romero, J., Silva, A., Guzmán, M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707960200 · Cited by 168 · see citing works

Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth

Wang, D., Wang, H., Wei, N., Backlund, M. G., Dey, S. K., & DuBois, R. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0896 · Cited by 166 · see citing works

Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity

Mehrpouya‐Bahrami, P., Chitrala, K. N., Ganewatta, M. S., Tang, C., Murphy, E. A., Enos, R. T., Velázquez, K. T., McCellan, J., Nagarkatti, M., & Nagarkatti, P. S. (2017) · Scientific Reports · doi:10.1038/s41598-017-15154-6 · Cited by 163 · see citing works

The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications

Horváth, B., Mukhopadhyay, P., Haskó, G., & Pacher, P. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.11.003 · Cited by 152 · see citing works

AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis

Kim, K., Moore, D. H., Makriyannis, A., & Abood, M. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.025 · Cited by 152 · see citing works

The Structure–Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation

Bow, E. W., & Rimoldi, J. M. (2016) · Perspectives in Medicinal Chemistry · doi:10.4137/pmc.s32171 · Cited by 151 · see citing works

Cannabinoids and cancer: pros and cons of an antitumour strategy

Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706632 · Cited by 151 · see citing works

CB 2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways

Montecucco, F., Burger, F., Mach, F., & Steffens, S. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01328.2007 · Cited by 151 · see citing works

Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling

Grabner, G. F., Zimmermann, R., Schicho, R., & Taschler, U. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.033 · Cited by 151 · see citing works

Pivotal Advance: Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis

Rajesh, M., Pan, H., Mukhopadhyay, P., Bátkai, S., Osei‐Hyiaman, D., Haskó, G., Liaudet, L., Gao, B., & Pacher, P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307180 · Cited by 150 · see citing works

Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis

Giacoppo, S., Pollastro, F., Grassi, G., Bramanti, P., & Mazzon, E. (2016) · Fitoterapia · doi:10.1016/j.fitote.2016.11.010 · Cited by 149 · see citing works

Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties

Balvers, M. G. J., Verhoeckx, K. C. M., Plastina, P., Wortelboer, H. M., Meijerink, J., & Witkamp, R. F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.06.006 · Cited by 145 · see citing works

Palmitoylethanolamide: A Natural Compound for Health Management

Clayton, P., Hill, M., Bogoda, N. O., Subah, S., & Venkatesh, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105305 · Cited by 145 · see citing works

Cannabinoid CB 2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats

Duncan, M., Mouihate, A., Mackie, K., Keenan, C. M., Buckley, N. E., Davison, J. S., Patel, K. D., Pittman, Q. J., & Sharkey, K. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90285.2008 · Cited by 145 · see citing works

Cannabinoids and autoimmune diseases: A systematic review

Katchan, V., David, P., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.02.008 · Cited by 143 · see citing works

The emerging role of the endocannabinoid system in cardiovascular disease

Pacher, P., & Steffens, S. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0145-8 · Cited by 139 · see citing works

Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins

Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., Simone, C. D., Rapino, C., Finazzi‐Agrò, A., & Maccarrone, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.004 · Cited by 137 · see citing works

Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review

Cooray, R., Gupta, V. B., & Suphioglu, C. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02054-6 · Cited by 137 · see citing works

Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation

BURSTEIN, S. H., & Zurier, R. B. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9084-5 · Cited by 135 · see citing works

The effects of Morinda citrifolia L. (noni) on the immune system: Its molecular mechanisms of action

Palu, '. K., Kim, A. H., West, B. J., Deng, S., Jensen, J. C., & White, L. (2007) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2007.10.023 · Cited by 132 · see citing works

The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings

Mallat, A., Teixeira-Clerc, F., Deveaux, V., Manin, S., & Lotersztajn, S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01397.x · Cited by 131 · see citing works

Differential changes in GPR55 during microglial cell activation

Pietr, M., Kozela, E., Levy, R., Rimmerman, N., Lin, Y. H., Stella, N., Vogel, Z., & Juknat, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.05.028 · Cited by 130 · see citing works

The Endocannabinoid System and Neurogenesis in Health and Disease

Galve‐Roperh, I., Aguado, T., Palazuelos, J., & Guzmán, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296407 · Cited by 129 · see citing works

Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back

Almogi‐Hazan, O., & Or, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124448 · Cited by 132 · see citing works

Pathophysiology and therapy of pruritus in allergic and atopic diseases

Buddenkotte, J., & Steinhoff, M. S. (2010) · Allergy · doi:10.1111/j.1398-9995.2010.01995.x · Cited by 126 · see citing works

Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver

Guillot, A., Hamdaoui, N., Bizy, A., Zoltani, K., Souktani, R., Zafrani, E., Mallat, A., Lotersztajn, S., & Lafdil, F. (2013) · Hepatology · doi:10.1002/hep.26598 · Cited by 125 · see citing works

The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis

Akhmetshina, A., Dees, C., Busch, N., Beer, J., Sarter, K., Zwerina, J., Zimmer, A., Distler, O., Schett, G. A., & Distler, J. H. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24395 · Cited by 126 · see citing works

The endocannabinoid system is modulated in response to spinal cord injury in rats

García‐Ovejero, D., Arévalo‐Martín, Á., Petrosino, S., Docagne, F., Hagen, C., Bisogno, T., Watanabe, M., Guaza, C., Marzo, V. D., & Molina‐Holgado, E. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.09.015 · Cited by 125 · see citing works

Cannabidiol reduces airway inflammation and fibrosis in experimental allergic asthma

Vuolo, F. S., Abreu, S. C., Michels, M., Xisto, D. G., Blanco, N. G., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A., dos Reis, C. M., Bahl, M., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.029 · Cited by 125 · see citing works

The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids

McAllister, S. D., Soroceanu, L., & Desprez, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9608-y · Cited by 139 · see citing works

The therapeutic potential of cannabinoids for movement disorders

Kluger, B. M., Triolo, P. M., Jones, W. E., & Jankovic, J. J. (2015) · Movement Disorders · doi:10.1002/mds.26142 · Cited by 123 · see citing works

The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

Siegmund, S., Qian, T., Minicis, S. D., Harvey-White, J. D., Kunos, G., Vinod, K. Y., Hungund, B. L., & Schwabe, R. F. (2007) · The FASEB Journal · doi:10.1096/fj.06-7717com · Cited by 123 · see citing works

The Endocannabinoid System and Extinction Learning

Lutz, B. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8004-x · Cited by 121 · see citing works

The Endocannabinoid System and Its Relevance for Nutrition

Maccarrone, M., Gasperi, V., Catani, M. V., Diep, T. A., Dainese, E., Hansen, H. S., & Avigliano, L. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104701 · Cited by 122 · see citing works

Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration†

Teixeira-Clerc, F., Belot, M., Manin, S., Deveaux, V., Cadoudal, T., Chobert, M.-N., Louvet, A., Zimmer, A., Tordjmann, T., Mallat, A., et al. (2010) · Hepatology · doi:10.1002/hep.23779 · Cited by 122 · see citing works

Therapeutic potential of cannabinoid medicines

Robson, P. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1529 · Cited by 124 · see citing works

Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF‐κB pathway inhibition

Nakajima, Y., Furuichi, Y., Biswas, K. K., Hashiguchi, T., Kawahara, K.-I., Yamaji, K., Uchimura, T., Izumi, Y., & Maruyama, I. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.079 · Cited by 118 · see citing works

Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats

Zamberletti, E., Gabaglio, M., Prini, P., Rubino, T., & Parolaro, D. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.09.021 · Cited by 114 · see citing works

Endocannabinoids and neurodegenerative diseases

Micale, V., Mazzola, C., & Drago, F. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.008 · Cited by 117 · see citing works

Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology

Marzo, V. D., Bisogno, T., & PETROCELLIS, L. D. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.05.014 · Cited by 116 · see citing works

Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study

Lahat, A., Lang, A., & Ben‐Horin, S. (2011) · Digestion · doi:10.1159/000332079 · Cited by 116 · see citing works

A Comprehensive Review on Cannabis sativa Ethnobotany, Phytochemistry, Molecular Docking and Biological Activities

Hourfane, S., Mechqoq, H., Bekkali, A. Y., Rocha, J. M., & Aouad, N. E. (2023) · Plants · doi:10.3390/plants12061245 · Cited by 125 · see citing works

Endocannabinoids: Friends and foes of reproduction

Maccarrone, M. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.07.001 · Cited by 116 · see citing works

Cannabinoids and Endocannabinoids in Metabolic Disorders with Focus on Diabetes

Marzo, V. D., Piscitelli, F., & Mechoulam, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_4 · Cited by 114 · see citing works

Prospects for cannabinoids as anti‐inflammatory agents

Zurier, R. B. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10291 · Cited by 57 · see citing works

Cannabinoids as Novel Anti-Inflammatory Drugs

Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555 · see citing works

The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation

Graczyk, M., Lewandowska, A. A., & Dzierżanowski, T. (2021) · Molecules · doi:10.3390/molecules26154551 · Cited by 35 · see citing works

Therapeutic Potential of Cannabinoid-Based Drugs

Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49 · see citing works

Therapeutic properties of cannabinoid drugs and marijuana in several disorders: A narrative review

Alvarado, R. N., Dirección General Adjunta de Políticas y Programas contra las Adicciones, C. N. C. L. A., Sánchez, R. M. D. C., Salcedo, V. V., Dirección General de Políticas y Programas contra las Adicciones, C. N. C. L. A., & Departamento de Investigación Clínica, I. N. D. P. R. D. L. F. M. (2017) · Salud Mental · doi:10.17711/sm.0185-3325.2017.014 · Cited by 6 · see citing works